Jane Lian to Drug Screening Assays, Antitumor
This is a "connection" page, showing publications Jane Lian has written about Drug Screening Assays, Antitumor.
Connection Strength
0.022
-
Kang BH, Siegelin MD, Plescia J, Raskett CM, Garlick DS, Dohi T, Lian JB, Stein GS, Languino LR, Altieri DC. Preclinical characterization of mitochondria-targeted small molecule hsp90 inhibitors, gamitrinibs, in advanced prostate cancer. Clin Cancer Res. 2010 Oct 01; 16(19):4779-88.
Score: 0.022